The Hemostatic effect of Badari Churna in excessive Menstrual Bleeding
Phase 2
- Conditions
- Health Condition 1: N920- Excessive and frequent menstruation with regular cycle
- Registration Number
- CTRI/2023/01/049104
- Lead Sponsor
- Dr. Kalyani Borse
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
The duration of bleeding must be > 7 days or quantity must be > 80 ml cycle or both.7
Patients with Uterine Fibroids , Adenomyosis , Endometriosis , Pelvic Inflammatory Disease.
Patients fulfilling diagnostic criteria and patients complaining of previous history of Asrugdara for at
least 2 consecutive cycle.
Exclusion Criteria
Patientâ??s suffering from severe Anemia.
Suspected cases of spontaneous, threatened or incomplete abortion.
Known cases of Diabetes Mellitus.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method